ArticleProceedings of the National Academy of Sciences of the United States of America2026

PHGDH phosphorylation mediated by WNK1 serves as a dual marker of metabolic vulnerability and responsiveness to oxaliplatin treatment.

Shaobo Fang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.